Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 19
2007 60
2008 102
2009 105
2010 92
2011 94
2012 98
2013 85
2014 83
2015 120
2016 77
2017 90
2018 98
2019 50
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

1,026 results
Results by year
Filters applied: . Clear all
Page 1
Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis.
Pepple KL, Lin P. Pepple KL, et al. Ophthalmology. 2018 Dec;125(12):1977-1983. doi: 10.1016/j.ophtha.2018.05.014. Epub 2018 Jul 4. Ophthalmology. 2018. PMID: 30458922 Free PMC article. Review.
A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis.
Bilal J, Berlinberg A, Bhattacharjee S, Trost J, Riaz IB, Kurtzman DJB. Bilal J, et al. J Dermatolog Treat. 2018 Sep;29(6):569-578. doi: 10.1080/09546634.2017.1422591. Epub 2018 Mar 28. J Dermatolog Treat. 2018. PMID: 29532693 Review.
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation.
Maxwell JR, Zhang Y, Brown WA, Smith CL, Byrne FR, Fiorino M, Stevens E, Bigler J, Davis JA, Rottman JB, Budelsky AL, Symons A, Towne JE. Maxwell JR, et al. Immunity. 2015 Oct 20;43(4):739-50. doi: 10.1016/j.immuni.2015.08.019. Epub 2015 Sep 29. Immunity. 2015. PMID: 26431947 Free article.
Targeting the interleukin-23/17 axis in axial spondyloarthritis.
Paine A, Ritchlin CT. Paine A, et al. Curr Opin Rheumatol. 2016 Jul;28(4):359-67. doi: 10.1097/BOR.0000000000000301. Curr Opin Rheumatol. 2016. PMID: 27152702 Free PMC article. Review.
Interleukin-23: A New Atherosclerosis Target.
Liu W, Chang C, Hu H, Yang H. Liu W, et al. J Interferon Cytokine Res. 2018 Oct;38(10):440-444. doi: 10.1089/jir.2018.0006. J Interferon Cytokine Res. 2018. PMID: 30328797 Review.
Interleukin-23 in the pathogenesis and treatment of psoriasis.
Kollipara R, Downing C, Gordon R, Tyring S. Kollipara R, et al. Skin Therapy Lett. 2015 Mar-Apr;20(2):1-4. Skin Therapy Lett. 2015. PMID: 25807335 Free article. Review.
Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response.
Sawyer LM, Malottki K, Sabry-Grant C, Yasmeen N, Wright E, Sohrt A, Borg E, Warren RB. Sawyer LM, et al. PLoS One. 2019 Aug 14;14(8):e0220868. doi: 10.1371/journal.pone.0220868. eCollection 2019. PLoS One. 2019. PMID: 31412060 Free PMC article.
Safety of biologics in psoriasis.
Kamata M, Tada Y. Kamata M, et al. J Dermatol. 2018 Mar;45(3):279-286. doi: 10.1111/1346-8138.14096. Epub 2017 Dec 10. J Dermatol. 2018. PMID: 29226369 Review.
1,026 results
Jump to page
Feedback